NCT05198323 - A Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects AIS Undergoing EVT | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 11, 2022

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions

Acute Ischemic Stroke

Interventions

DRUG

LT3001 Drug Product

LT3001 Drug Product administered once by intravenous infusion

DRUG

Placebo

Placebo administered once by intravenous infusion

Trial Locations (2)

RECRUITING

CHI Memorial Hospital, Chattanooga

RECRUITING

Taichung Medical University, Taichung